AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)

Recruiting

Phase 1

AV-1980RAV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)

Sponsor:

Institute for Molecular Medicine

Code:

NCT07158905

Conditions

Alzheimer Disease

Preclinical Alzheimer's Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

AV-1980R 20 µg

AV-1980R 60 µg

AV-1980R 180 µg

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-20. This information was provided to ClinicalTrials.gov by Institute for Molecular Medicine on 2026-06-26.